Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD OF TREATING OBESITY WITH A LUTEINIZING HORMONE RECEPTOR AGONIST
Document Type and Number:
WIPO Patent Application WO/2023/239854
Kind Code:
A3
Abstract:
The present disclosure is directed to methods of treating or preventing obesity with a luteinizing hormone receptor agonist. More particularly, provided herein are methods of treating obesity in a subject in need thereof, comprising administering to the subject in need thereof a thieno[2,3-d]pyrimidine derivative.

More Like This:
JP2024505509Pharmaceutical compositions of CGRP inhibitors and methods of using them
JP5697260Diabetes treatment or prophylaxis
JP2005060247ISOQUINOLINONE DERIVATIVE AND ITS PRODUCTION METHOD AND USE
Inventors:
LIZNEVA DARIA (US)
ZAIDI MONE (US)
YUEN TONY (US)
Application Number:
PCT/US2023/024822
Publication Date:
January 18, 2024
Filing Date:
June 08, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ICAHN SCHOOL MED MOUNT SINAI (US)
International Classes:
A61P3/04; C07D495/06
Foreign References:
US20110200580A12011-08-18
US20040180873A12004-09-16
Other References:
DATABASE PubChem NCBI; ANONYMOUS : "5-amino-2-methylsulfanyl-4-[3-(2-morpholin-4-yl-acetylamino)-phenyl]-thieno[2,3-d]pyrimidine-6-carboxylic acid t-butylamide", XP093130756
Attorney, Agent or Firm:
BABATZ, Timothy et al. (US)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: SCREENING MODELS AND METHODS OF CANCER TREATMENT

Next Patent: OPTICAL PATTERN DECODING IN A REAL SCENE USING OVERLAY FUNCTIONALITY